RE:Life science leader When I read his comments, I feel like his tenure at Thera has been an expiriment and not a very succesful one at that. The board failed at preventing the outcome we have at the moment considering his inexperience of biotech and running a public company. The CFO was not Luc, considering the deals we got we know that now. The IR was a priority when it was bas and has now become a liability ifor shareholders. It is destroying value at this point. I know somebody won't agree with me of course and will verbalise it but that person is on ignore now. My opinion is that the CEO was a rookie in some important areas of the job and that the board, CGO and IR failed us at supervising and adressing the problem. That is why I will vote to cast the out and putt forward a new path to the futur that could be a strategic review process to sell the company.